Relmada Therapeutics (RLMD)
(Delayed Data from NSDQ)
$3.53 USD
-0.27 (-7.11%)
Updated May 10, 2024 04:00 PM ET
After-Market: $3.54 +0.01 (0.28%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.83 |
EPS Last Quarter | -0.72 |
Last EPS Surprise | 20.00% |
ABR | 2.50 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.04 |
Next Year | -2.94 |
EPS (TTM) | -3.13 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.83 | -0.74 | -3.04 | -2.94 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.95 | -0.68 | -3.25 | NA |
High Estimate | -0.79 | -0.61 | -2.85 | -1.45 |
Low Estimate | -0.86 | -0.86 | -3.22 | -4.42 |
Year ago EPS | -0.84 | -0.73 | -3.28 | -3.04 |
Year over Year Growth Est. | 1.19% | -1.37% | 7.32% | 3.29% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 2 | 2 | 2 | 1 |
Up Last 30 Days | 2 | 2 | 2 | 1 |
Up Last 60 Days | 1 | 1 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 1 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.83 | -0.74 | -3.04 | -2.94 |
7 Days Ago | -0.94 | -0.84 | -3.53 | -2.86 |
30 Days Ago | -0.94 | -0.84 | -3.53 | -2.86 |
60 Days Ago | -1.01 | -0.95 | -3.55 | -1.60 |
90 Days Ago | -1.01 | -0.95 | -3.55 | -1.60 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.83 | -0.74 | -3.04 | -2.94 |
Zacks Consensus Estimate | -0.83 | -0.74 | -3.04 | -2.94 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.72 | -0.84 | -0.73 | -0.84 | NA |
Estimate | -0.90 | -0.88 | -0.95 | -0.92 | NA |
Difference | 0.18 | 0.04 | 0.22 | 0.08 | 0.13 |
Surprise | 20.00% | 4.55% | 23.16% | 8.70% | 14.10% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more